EUVIMEDEUVIMED entdecken
Crossref

The chronic pharmacological antagonism of the CB1 receptor is not involved in the behavioral effects of antidepressants administered in mice submitted to chronic unpredictable stress

Melissa A Ribeiro, Rafael P Aguiar, Franciele F Scarante, Eduardo J Fusse, Rúbia M W de Oliveira, Francisco S Guimarães, Alline C Campos

Behavioural Brain Research · 2023

DOI: 10.1016/j.bbr.2023.114502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2023. Verfasst von Melissa A Ribeiro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, State University of Maringá, 5790 Colombo Ave, Maringá, Paraná, Brazil. Hauptthemen laut MEDLINE: Drug Inverse Agonism, Anti-Anxiety Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several pieces of evidence suggest that the monoaminergic theory of depression cannot fully explain all behavioral and neuroplastic changes observed after antidepressant chronic treatment. Other molecular targets, such as the endocannabinoid system, have been associated with the chronic effects of these drugs. In the present study, we hypothesized that the behavioral and neuroplastic effects observed after repeated treatment with the antidepressants (AD) Escitalopram (ESC) or venlafaxine (VFX) in chronically stressed mice depend on CB1 receptor activation. Male mice submitted to the chronic unpredictable stress (CUS) paradigm for 21 days were treated with Esc (10 mg/kg) or VFX (20 mg/kg) once a day in the presence or not of AM251 (0.3 mg/kg), a CB1 receptor antagonist/inverse agonist. At the end of the CUS paradigm, we conducted behavior tests to evaluate depressive- and anxiety-like behaviors. Our results demonstrated that chronic blockade of the CB1 receptor does not attenuate the antidepressant- or the anxiolytic-like effects of ESC nor VFX. ESC increased the expression of CB1 in the hippocampus, but AM251 did not change the pro-proliferative effects of ESC in the dentate gyrus or the increased expression of synaptophysin induced by this AD in the hippocampus. Our results suggest that CB1 receptors are not involved in behavioral and hippocampal neuroplastic effects observed after repeated antidepressant treatment in mice submitted to CUS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Inverse AgonismAnti-Anxiety AgentsMiceMaleAnimalsAntidepressive AgentsHippocampusDepressionEndocannabinoidsVenlafaxine HydrochlorideStress, PsychologicalReceptor, Cannabinoid, CB1

Stichwörter der Autor:innen

AntidepressantCB(1) receptorChronic unpredictable stressHippocampusMiceNeuroplasticity

Substanzen

Antidepressive AgentsEndocannabinoidsAnti-Anxiety AgentsVenlafaxine HydrochlorideReceptor, Cannabinoid, CB1

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, State University of Maringá, 5790 Colombo Ave, Maringá, Paraná, Brazil.
  • Mental Health Graduate Program, Ribeirão Preto Medical School, University of São Paulo, 2650 Tenente Catão Roxo Ave, Ribeirão Preto, São Paulo, Brazil.
  • Department of Pharmacology and Therapeutics, State University of Maringá, 5790 Colombo Ave, Maringá, Paraná, Brazil. Electronic address: allinecampos@usp.br.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Ribeiro, M. A., Aguiar, R. P., Scarante, F. F., Fusse, E. J., de Oliveira, R. M. W., Guimarães, F. S., & Campos, A. C. (2023). The chronic pharmacological antagonism of the CB1 receptor is not involved in the behavioral effects of antidepressants administered in mice submitted to chronic unpredictable stress. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2023.114502

Vancouver

Ribeiro MA, Aguiar RP, Scarante FF, Fusse EJ, de Oliveira RMW, Guimarães FS, et al. The chronic pharmacological antagonism of the CB1 receptor is not involved in the behavioral effects of antidepressants administered in mice submitted to chronic unpredictable stress. Behavioural Brain Research. 2023. doi:10.1016/j.bbr.2023.114502

BibTeX
@article{Ribeiro2023,
  author = {Ribeiro, Melissa A and Aguiar, Rafael P and Scarante, Franciele F and Fusse, Eduardo J and de Oliveira, Rúbia M W and Guimarães, Francisco S and Campos, Alline C},
  title = {The chronic pharmacological antagonism of the CB1 receptor is not involved in the behavioral effects of antidepressants administered in mice submitted to chronic unpredictable stress},
  journal = {Behavioural Brain Research},
  year = {2023},
  doi = {10.1016/j.bbr.2023.114502}
}
Kostenlos starten →